Business
Vitaco Health Group lists on ASX
Vitaco Health Group—the company behind nutritional products including Aussie Bodies, Nutra-Life, Healtheries and Musashi—today made its debut on the ASX, positioning the company for the next phase of its growth. …
Terry White group announces profits, name change, outlook
Terry White Group Limited, the parent of pharmacy franchisors Terry White Management and Chemplus, has announced Net Profit After Tax of $1.2 million, on the back of a 16% increase …
CM exports to Asia more than double over past year
On the eve of the Vitafoods Asia expo in Hong Kong, one of the premier events for the global complementary medicines industry, Complementary Medicines Australia has welcomed the latest AusTrade …
ACCC okays Pfizer’s Hospira acquisition
The Australian Competition and Consumer Commission has announced that it will not oppose Pfizer Inc’s proposed $US17 billion acquisition of Hospira Inc. “Pfizer and Hospira are also the two largest …
Slade to purchase Fresenius Kabi oncology compounding business
Slade Pharmacy Services has entered into agreements with Fresenius Kabi to purchase its Oncology Compounding Business in Australia. This includes all the TGA-licenced compounding facilities in Queensland, NSW and Victoria. …
Novartis to acquire Spinifex, continue pain drug development
Novartis is to acquire Spinifex Pharmaceuticals, a company focused on the development of new drugs for treating chronic pain. Spinifex Pharmaceuticals, Inc. and its Australian subsidiary Spinifex Pharmaceuticals Pty Ltd, …
Sigma commits to another five years with Reform Management
Sigma Pharmaceuticals Limited has confirmed a new five-year wholesale supply and services agreement with Reform Management. With more than 1,900 independent community pharmacy customers nationally, Reform has one of the …
Chemplus merges with Terry White Management
Chemplus, which supports the South Australian pharmacy network of the same name, is set to merge with Terry White Management in a strategic move to “future-proof” its member pharmacies. Chemplus …
Strides buys at Aspen, revives Arrow Pharmaceuticals
Indian pharma company Strides Arcolab has acquired Aspen business in Australia and plans to run the business as Arrow Pharmaceuticals, bringing back a previous name in the Australian generics market. …
API profits up
API has reported a net profit after tax of $21.3 million for the six months to 28 February 2015. This is above the guidance of $21.1 million provided on 4 …
GSK, Novartis get ACCC okay to restructure
The Australian Competition and Consumer Commission says it won’t oppose GlaxoSmithKline’s and Novartis’ transactions involving over-the-counter consumer products, human vaccines and oncology products. As a result of the transactions: GSK …
CSL profits up
Double digit sales growth in albumin and speciality products and influenza vaccine sales have helped CSL announce a net profit after tax of US$692m (A$889m) for the six months ended …